NDC 0615-8505
Bupropion Hydrochloride 300 mg tablet, extended release
On the label: NCS HealthCare of KY, Inc dba Vangard Labs. It's repackaged: NCS HealthCare of KY, Inc dba Vangard Labs rebottles it from Rising Pharma Holdings, Inc.'s NDC 16571-863.
Where the pills inside were made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Graviti Pharmaceuticals Private Limited | Sangareddy, India | Makes it and tests it | Problems found, fixed voluntarilyJul 28, 2026 · 2 inspections |
Repackaging site
- NCS HealthCare of KY, LLC dba Vangard Labs, Glasgow, KY, United States · repackages it
Recalls
- Sep 15, 2025 · Class II · Graviti Pharmaceuticals Private Limited
Failed Tablet/Capsule Specifications
Lots: Batch # BPB124341A, Exp date: 10/2026
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Bupropion: every company that makes it
- Form
- tablet, extended release, oral
- Strength
- 300 mg
- Approval
- ANDA ANDA211020
- On the market since
- Aug 1, 2022
- Package NDCs
0615-8505-050615-8505-39- Official label
- DailyMed (National Library of Medicine), updated Aug 12, 2024
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?